Board of Directors, Chair of Audit and Risk Committee, Member of Remuneration and Nomination Committee @ (August 2023 - June 2026)
Chief Financial Officer @ TCR² Therapeutics Inc. (Acquired by Adaptimmune on 6/1/23) (January 2022 - June 2023)
Chief Financial Officer and Chief Operating Officer @ (January 2019 - January 2022)
Senior Vice President Finance @ Gemini Therapeutics (January 2018 - January 2019)
SVP Finance and Operations @ (January 2017 - January 2018)
VP Finance and Treasurer and Principal Accounting Officer @ (January 2013 - January 2017)
Corporate Controller @ (January 2008 - January 2013)
Audit Manager @ (January 2001 - January 2007)
Eric Sullivan Education
Bentley University
Eric Sullivan Skills
Sarbanes-Oxley Act
Financial Analysis
SEC filings
Financial Reporting
Pharmaceutical Industry
Revenue Recognition
Auditing
Due Diligence
Mergers & Acquisitions
US GAAP
Forecasting
Finance
Accounting
Management
Internal Controls
Financial Modeling
Wisdom Teeth
Eric Sullivan Summary
Eric Sullivan, based in Cambridge, MA, US, is currently a Chief Financial Officer at Convergent Therapeutics, Inc.. Eric Sullivan brings experience from previous roles at Chimeric Therapeutics, TCR² Therapeutics Inc. (Acquired by Adaptimmune on 6/1/23), Triplet Therapeutics and Gemini Therapeutics. Eric Sullivan holds a Bentley University. With a robust skill set that includes Sarbanes-Oxley Act, Financial Analysis, SEC filings, Financial Reporting, Pharmaceutical Industry and more. Eric Sullivan has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Eric Sullivan?
Find contact details for 700 million professionals.